The Medical Device Innovation Consortium (MDIC), in partnership with Axendia, Inc. is conducting a research survey seeking to uncover the internal and external barriers medical device companies must overcome […]
The Good, The Bad and The Ugly In the rapidly evolving landscape of life sciences, generative AI (GEN AI) stands as a beacon of innovation,
The State of Generative AI In Life Sciences: New Market Research Read More »
An Axendia Voice of The Customer Report The need for clinical evidence on medical devices is steadily increasing – for regulatory submissions, postmarket surveillance, reimbursement,
Developing Med Tech Clinical Evidence: Challenges and New Approaches Read More »
An Axendia Market Readiness Assessment Report While most biopharma companies have complex stage-gate product development, change management and investigation processes, they lack the ability to
Accelerating Time To Market with Biopharma PLM Read More »
Axendia Analysis of “Successes and Opportunities in Modeling & Simulation for FDA” The last thing you want is to lag your regulator and in the
FDA Is Using Modeling & Simulation. Why Aren’t You? Read More »
Research Report This report highlights how life-sciences companies are reimagining the way they operate by leveraging advanced manufacturing technologies. We think you’ll find the results
The Needle is Moving: Digital Transformation in Life Sciences Manufacturing Read More »
An Axendia Research Report Featuring Industry Executive Insights A top priority for patients, payers, providers, and regulators is available, affordable healthcare. The medical products1 industry
Improving Healthcare Outcomes by Rewarding Value, NOT Cost Read More »
An Axendia Insight Brief The demand for organizational visibility, control, and collaboration to achieve resilience during unprecedented times is a catalyst to digital transformation in
Transforming Quality in the Cloud Read More »
An Axendia Market Research Report Medical device organizations are continuing to sharpen their focus on developing high-quality medical devices aimed at improving patient outcomes. However,
A Roadmap to the Agency’s Modernization Action Plans As Life-Science manufacturers embrace new technologies to speed time to market and products become more complex, the
FDA’s Digital Transformation Journey Read More »
The factory of the future goes beyond the traditional factory walls By: Sandra K. Rodriguez, Senior Industry Analyst The need for organizational visibility, control, and
Reinventing the Value Network with the Factory of the Future Read More »
An open Letter to the Life-Sciences Industry on Analyst Forced Vendor Rankings By: Daniel R. Matlis As a Life-Science Industry Analyst, I am often asked
Q: Who is the Best Technology Vendor? A: NONE! Read More »
